For following the competition: what moved in each program, several studies read as one move.
- Anti-EGFR/Anti-CDCP1-MMAE Antibody-Drug Conjugate IDP-001
- pelareorep
- Anti-ULBP2/5/6/CD3/CD2 Trispecific T-cell Engager EVOLVE104
Mondays · ranked, phase 3 first · readouts ahead · See a sample brief
Add Anus Neoplasms to watchlistEvery Monday by email · turn it off any timePro · free during the beta